AAAAAA
Results: 1-25/309
Authors:
Silvers, LE
Ellenberg, SS
Wise, RP
Varricchio, FE
Mootrey, GT
Salive, ME
Citation: Le. Silvers et al., The epidemiology of fatalities reported to the Vaccine Adverse Event Reporting System 1990-1997, PHARMA D S, 10(4), 2001, pp. 279-285
Authors:
Bourgault, C
Elstein, E
Baltzan, MA
Le Lorier, J
Suissa, S
Citation: C. Bourgault et al., Antihypertensives and myocardial infarction risk: the modifying effect of history of drug use, PHARMA D S, 10(4), 2001, pp. 287-294
Authors:
McManus, P
Birkett, DJ
Dudley, J
Stevens, A
Citation: P. Mcmanus et al., Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia, PHARMA D S, 10(4), 2001, pp. 295-300
Authors:
Arlett, PR
Harrison, P
Citation: Pr. Arlett et P. Harrison, Compliance in European pharmacovigilance: a regulatory view, PHARMA D S, 10(4), 2001, pp. 301-302
Authors:
Aziz, EE
Ayis, S
Gould, FK
Rawlins, MD
Citation: Ee. Aziz et al., Risk factors for the development of Clostridium difficile toxin-associateddiarrhoea: a pilot study, PHARMA D S, 10(4), 2001, pp. 303-308
Authors:
Unsworth, L
Walley, T
Citation: L. Unsworth et T. Walley, Trends in primary care antibiotic prescribing in England 1994-1998, PHARMA D S, 10(4), 2001, pp. 309-314
Authors:
Beimfohr, C
Maziak, W
von Mutius, E
Hense, HW
Leupold, W
Hirsch, T
Keil, U
Weiland, SK
Citation: C. Beimfohr et al., The use of anti-asthmatic drugs in children: results of a community-based survey in Germany, PHARMA D S, 10(4), 2001, pp. 315-321
Authors:
Jhaj, R
Bhargava, VK
Uppal, R
Lekha, S
Reeta, K
Kaur, N
Citation: R. Jhaj et al., Use of cold medications for upper respiratory tract infections in children, PHARMA D S, 10(4), 2001, pp. 323-327
Authors:
Clinard, F
Sgro, C
Bardou, M
Dumas, M
Hillon, P
Bonithon-Kopp, C
Citation: F. Clinard et al., Non-steroidal anti-inflammatory drug prescribing patterns in general practice: comparison of a general practitioner-based survey and a pharmacy-basedsurvey in France, PHARMA D S, 10(4), 2001, pp. 329-338
Authors:
Bleumink, GS
Veld, BAI
Stricker, BHC
Citation: Gs. Bleumink et al., European pharmacovigilance legislation: has it led to implementation of pharmacovigilance inspections?, PHARMA D S, 10(4), 2001, pp. 339-340
Authors:
Wang, JX
Donnan, PT
Citation: Jx. Wang et Pt. Donnan, Propensity score methods in drug safety studies: practice, strengths and limitations, PHARMA D S, 10(4), 2001, pp. 341-344
Authors:
Gross, R
Citation: R. Gross, Proactive Surveillance Symposium: the direction and needs of drug safety in the 21st century, PHARMA D S, 10(3), 2001, pp. 189-189
Authors:
Bortnichak, EA
Wise, RP
Salive, ME
Tilson, HH
Citation: Ea. Bortnichak et al., Proactive safety surveillance, PHARMA D S, 10(3), 2001, pp. 191-196
Authors:
Kaufman, DW
Rosenberg, L
Mitchell, AA
Citation: Dw. Kaufman et al., Signal generation and clarification: use of case-control data, PHARMA D S, 10(3), 2001, pp. 197-203
Authors:
Uhl, K
Honig, P
Citation: K. Uhl et P. Honig, Risk management of marketed drugs: FDA and the interface with the practiceof medicine, PHARMA D S, 10(3), 2001, pp. 205-208
Authors:
Smalley, W
Citation: W. Smalley, Drug safety: can simple interventions be effective in a complex world?, PHARMA D S, 10(3), 2001, pp. 209-210
Authors:
Weatherby, LB
Walker, AM
Fife, D
Vervaet, P
Klausner, MA
Citation: Lb. Weatherby et al., Contraindicated medications dispensed with cisapride: temporal trends in relation to the sending of 'Dear Doctor' letters, PHARMA D S, 10(3), 2001, pp. 211-218
Authors:
Al Khaja, KAJ
Sequeira, RP
Wahab, AWMA
Mathur, VS
Citation: Kaj. Al Khaja et al., Antihypertensive drug prescription trends at the primary health care centres in Bahrain, PHARMA D S, 10(3), 2001, pp. 219-227
Authors:
Sabo, A
Stanulovic, M
Jakovljevic, V
Grujic, Z
Citation: A. Sabo et al., Collaborative study on drug use in pregnancy: the results of the follow-up10 years after (Novi Sad Centre), PHARMA D S, 10(3), 2001, pp. 229-235
Authors:
Balakrishnan, S
Bambery, P
Gupta, N
Pandhi, P
Citation: S. Balakrishnan et al., An audit of the use of antirheumatic drugs in a North Indian referral hospital, PHARMA D S, 10(3), 2001, pp. 237-243
Authors:
Berard, A
Kahn, SR
Abenhaim, L
Citation: A. Berard et al., Is hormone replacement therapy protective for venous ulcer of the lower limbs?, PHARMA D S, 10(3), 2001, pp. 245-251
Authors:
Donnan, PT
Wang, JX
Citation: Pt. Donnan et Jx. Wang, The case-crossover and case-time-control designs in pharmacoepidemiology, PHARMA D S, 10(3), 2001, pp. 259-262
Authors:
Gilmore, A
Milne, R
Citation: A. Gilmore et R. Milne, Methylphenidate in children with hyperactivity: review and cost-utility analysis, PHARMA D S, 10(2), 2001, pp. 85-94
Authors:
Emerson, A
Martin, RM
Tomlin, M
Mann, RD
Citation: A. Emerson et al., Prospective cohort study of adverse events monitored by hospital pharmacists, PHARMA D S, 10(2), 2001, pp. 95-103
Authors:
Wang, JX
Donnan, PT
Steinke, D
MacDonald, TM
Citation: Jx. Wang et al., The multiple propensity score for analysis of dose-response relationships in drug safety studies, PHARMA D S, 10(2), 2001, pp. 105-111